Goldman Sachs
REPL icon

Goldman Sachs’s Replimune Group REPL Stock Holding History

Goldman Sachs’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4M Buy
2,277,276
+1,619,180
+246% +$12.4M ﹤0.01% 2567
2025
Q4 		$6.4M Sell
658,096
-476,655
-42% -$4.05M ﹤0.01% 3516
2025
Q3 		$4.75M Buy
1,134,751
+17,420
+2% +$111K ﹤0.01% 3695
2025
Q2 		$10.4M Buy
1,117,331
+427,164
+62% +$3.73M ﹤0.01% 2723
2025
Q1 		$6.73M Buy
690,167
+119,145
+21% +$1.47M ﹤0.01% 3063
2024
Q4 		$6.92M Sell
571,022
-48,490
-8% -$589K ﹤0.01% 3132
2024
Q3 		$6.79M Sell
619,512
-46,565
-7% -$473K ﹤0.01% 3080
2024
Q2 		$5.99M Buy
666,077
+152,737
+30% +$1.06M ﹤0.01% 2993
2024
Q1 		$4.19M Sell
513,340
-1,725,543
-77% -$14.2M ﹤0.01% 3261
2023
Q4 		$18.9M Buy
2,238,883
+1,679,553
+300% +$19.5M ﹤0.01% 1952
2023
Q3 		$9.57M Sell
559,330
-53,443
-9% -$1.05M ﹤0.01% 2425
2023
Q2 		$14.2M Sell
612,773
-31,424
-5% -$614K ﹤0.01% 2133
2023
Q1 		$11.4M Buy
644,197
+494,009
+329% +$11.7M ﹤0.01% 2299
2022
Q4 		$4.09M Sell
150,188
-34,788
-19% -$723K ﹤0.01% 3347
2022
Q3 		$3.19M Sell
184,976
-40,724
-18% -$777K ﹤0.01% 3548
2022
Q2 		$3.94M Buy
225,700
+84,123
+59% +$1.38M ﹤0.01% 3381
2022
Q1 		$2.4M Buy
141,577
+36,326
+35% +$685K ﹤0.01% 4097
2021
Q4 		$2.85M Sell
105,251
-135,699
-56% -$4.06M ﹤0.01% 3939
2021
Q3 		$7.14M Buy
240,950
+26,252
+12% +$853K ﹤0.01% 3039
2021
Q2 		$8.25M Sell
214,698
-214,796
-50% -$7.35M ﹤0.01% 2877
2021
Q1 		$13.1M Buy
429,494
+183,951
+75% +$6.89M ﹤0.01% 2312
2020
Q4 		$9.37M Buy
245,543
+188,189
+328% +$7.84M ﹤0.01% 2528
2020
Q3 		$1.32M Buy
57,354
+23,019
+67% +$525K ﹤0.01% 3878
2020
Q2 		$854K Buy
34,335
+4,585
+15% +$81.1K ﹤0.01% 4065
2020
Q1 		$297K Sell
29,750
-2,905
-9% -$43.3K ﹤0.01% 4508
2019
Q4 		$469K Sell
32,655
-60,049
-65% -$865K ﹤0.01% 4542
2019
Q3 		$1.29M Sell
92,704
-15,924
-15% -$195K ﹤0.01% 3859
2019
Q2 		$1.59M Buy
108,628
+82,573
+317% +$1.19M ﹤0.01% 3680
2019
Q1 		$397K Sell
26,055
-20,253
-44% -$252K ﹤0.01% 4514
2018
Q4 		$463K Buy
46,308
+33,927
+274% +$459K ﹤0.01% 4406
2018
Q3 		$199K Buy
+12,381
New +$217K ﹤0.01% 4927

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs's REPL Position: Q1 2026 in Review

Goldman Sachs increased its Replimune Group (REPL) stake by 246% in Q1 2026, buying an estimated $12.4M and bringing the position to 2,277,276 shares worth $17.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

Goldman Sachs first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $18.9M in Q4 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Goldman Sachs held 2,277,276 shares of Replimune Group worth $17.4M as of Q1 2026.
  • Goldman Sachs bought 1,619,180 Replimune Group shares in Q1 2026, an estimated $12.4M.
  • Replimune Group made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2567 holding.
  • Goldman Sachs first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Goldman Sachs's Replimune Group position peaked at $18.9M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.